BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12208768)

  • 1. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
    McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
    Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
    J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.
    Huang S; Mills L; Mian B; Tellez C; McCarty M; Yang XD; Gudas JM; Bar-Eli M
    Am J Pathol; 2002 Jul; 161(1):125-34. PubMed ID: 12107097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
    Wu GJ; Fu P; Wang SW; Wu MW
    Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.
    Sers C; Riethmüller G; Johnson JP
    Cancer Res; 1994 Nov; 54(21):5689-94. PubMed ID: 7923217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
    Rummel MM; Sers C; Johnson JP
    Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.
    Melnikova VO; Bar-Eli M
    Pigment Cell Res; 2006 Oct; 19(5):395-405. PubMed ID: 16965268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
    Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
    J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
    Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
    Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
    Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro.
    Burrows FJ; Haskard DO; Hart IR; Marshall JF; Selkirk S; Poole S; Thorpe PE
    Cancer Res; 1991 Sep; 51(18):4768-75. PubMed ID: 1680022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.